The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 4,145 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
908 DEVICES INC | COM | 65443P102 | 4,271 | 75,000 | SH | OTR | 75,000 | 0 | 0 | ||
ABBVIE INC | COM | 00287Y109 | 123,223 | 1,150,000 | SH | OTR | 1,150,000 | 0 | 0 | ||
ACACIA COMMUNICATIONS INC | COM | 00401C108 | 7,296 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 332,644 | 2,600,000 | SH | OTR | 2,600,000 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 16,260 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 43,330 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 9,378 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 198,589 | 853,300 | SH | OTR | 853,300 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 45,490 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 632,593 | 361,094 | SH | OTR | 361,094 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 2,520 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 28,863 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
AMYRIS INC | COM NEW | 03236M200 | 108,063 | 17,500,000 | SH | OTR | 17,500,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 38,978 | 1,557,261 | SH | OTR | 1,557,261 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 409,390 | 1,275,000 | SH | OTR | 1,275,000 | 0 | 0 | ||
AON PLC | SHS CL A | G0403H108 | 479,903 | 2,271,514 | SH | OTR | 2,271,514 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 130,130 | 2,275,000 | SH | OTR | 2,275,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | NOTE 3.500% 9/1 | 03753UAB2 | 5,930 | 3,522,000 | PRN | OTR | 3,522,000 | 0 | 0 | ||
ARAMARK | COM | 03852U106 | 424,202 | 11,023,949 | SH | OTR | 11,023,949 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 57,623 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 5,187 | 67,600 | SH | OTR | 67,600 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 166,780 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
ATENTO S A | SHS | L0427L204 | 18,227 | 2,230,357 | SH | OTR | 2,230,357 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 11,082 | 795,000 | SH | OTR | 795,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 66,900 | 1,967,060 | SH | OTR | 1,967,060 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 25,221 | 103,000 | SH | OTR | 103,000 | 0 | 0 | ||
BLACKSTONE GROUP INC | COM CL A | 09260D107 | 252,233 | 3,891,886 | SH | OTR | 3,891,886 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 475,918 | 13,238,319 | SH | OTR | 13,238,319 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 15,508 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 14,768 | 21,400,000 | SH | OTR | 21,400,000 | 0 | 0 | ||
BROADCOM INC | COM | 11135F101 | 272,778 | 622,995 | SH | OTR | 622,995 | 0 | 0 | ||
BROADMARK RLTY CAP INC | COM | 11135B100 | 73,136 | 7,170,213 | SH | OTR | 7,170,213 | 0 | 0 | ||
BROADMARK RLTY CAP INC | *W EXP 11/15/202 | 11135B118 | 1,937 | 7,174,613 | SH | OTR | 7,174,613 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 37,295 | 2,465,000 | SH | OTR | 2,465,000 | 0 | 0 | ||
CASCADE ACQUISITION CORP | UNIT 99/99/9999 | 147151203 | 10,346 | 990,000 | SH | OTR | 990,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 411,206 | 6,850,000 | SH | OTR | 6,850,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/202 | 15678U102 | 758 | 134,175 | SH | OTR | 134,175 | 0 | 0 | ||
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 361,822 | 546,931 | SH | OTR | 546,931 | 0 | 0 | ||
CLEVER LEAVES HOLDINGS INC | COM | 186760104 | 28,730 | 2,478,079 | SH | OTR | 2,478,079 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | NOTE 1.250% 5/0 | 189464AC4 | 36,077 | 51,910,000 | PRN | OTR | 51,910,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 6,738 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 21,600 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
CORELOGIC INC | COM | 21871D103 | 44,384 | 574,028 | SH | OTR | 574,028 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 5,938 | 725,000 | SH | OTR | 725,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 49,872 | 2,400,000 | SH | OTR | 2,400,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 17,121 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
DERMTECH INC | COM | 24984K105 | 27,934 | 861,090 | SH | OTR | 861,090 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 74,728 | 1,775,000 | SH | OTR | 1,775,000 | 0 | 0 | ||
EQUIFAX INC | COM | 294429105 | 71,483 | 370,684 | SH | OTR | 370,684 | 0 | 0 | ||
EQUILLIUM INC | COM | 29446K106 | 3,745 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 220,770 | 11,000,000 | SH | OTR | 11,000,000 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 315,228 | 1,154,005 | SH | OTR | 1,154,005 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 272,790 | 3,000,000 | SH | OTR | 3,000,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 70,471 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 445,474 | 3,149,118 | SH | OTR | 3,149,118 | 0 | 0 | ||
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 6,804 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 64,321 | 2,268,819 | SH | OTR | 2,268,819 | 0 | 0 | ||
GOL LINHAS AEREAS INTELIGENT | SPON ADR PFD NEW | 38045R206 | 843 | 85,838 | SH | OTR | 85,838 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 9,032 | 10,000,000 | PRN | OTR | 10,000,000 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 20,561 | 1,115,000 | SH | OTR | 1 | 1,115,000 | 0 | 0 | |
HILTON WORLDWIDE HLDGS INC | COM | 43300A203 | 182,515 | 1,640,437 | SH | OTR | 1,640,437 | 0 | 0 | ||
HOWMET AEROSPACE INC | COM | 443201108 | 139,603 | 4,891,479 | SH | OTR | 4,891,479 | 0 | 0 | ||
HUMANCO ACQUISITION CORP | UNIT 12/08/2023 | 44487N208 | 4,408 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 6,450 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | 16,815 | 510,000 | SH | OTR | 510,000 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 36,552 | 32,500,000 | PRN | OTR | 32,500,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 12,240 | 225,000 | SH | OTR | 225,000 | 0 | 0 | ||
INVENTIVA SA | ADS | 46124U107 | 2,320 | 160,000 | SH | OTR | 160,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 42,405 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 278,400 | 6,000,000 | SH | OTR | 6,000,000 | 0 | 0 | ||
IQIYI INC | NOTE 3.750%12/0 | 46267XAB4 | 29,894 | 29,689,000 | PRN | OTR | 29,689,000 | 0 | 0 | ||
IQIYI INC | NOTE 2.000% 4/0 | 46267XAD0 | 71,760 | 81,762,000 | PRN | OTR | 81,762,000 | 0 | 0 | ||
IQIYI INC | NOTE 4.000%12/1 | 46267XAE8 | 20,000 | 20,000,000 | PRN | OTR | 20,000,000 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 724,475 | 4,043,506 | SH | OTR | 4,043,506 | 0 | 0 | ||
ISIS PHARMACEUTICALS INC DEL | NOTE 1.000%11/1 | 464337AJ3 | 2,733 | 2,500,000 | PRN | OTR | 2,500,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 5,215 | 754,740 | SH | OTR | 754,740 | 0 | 0 | ||
KANSAS CITY SOUTHERN | COM NEW | 485170302 | 72,344 | 354,400 | SH | OTR | 354,400 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 71,113 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 43,527 | 35,000,000 | PRN | OTR | 35,000,000 | 0 | 0 | ||
KE HLDGS INC | SPONSORED ADS | 482497104 | 21,108 | 343,000 | SH | OTR | 343,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 9,945 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 31,500 | 525,000 | SH | OTR | 525,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 4,083 | 125,000 | SH | OTR | 125,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 35,749 | 2,650,000 | SH | OTR | 2,650,000 | 0 | 0 | ||
LUFAX HOLDING LTD | ADS REP SHS CL A | 54975P102 | 76,080 | 5,357,750 | SH | OTR | 5,357,750 | 0 | 0 | ||
MARVELL TECHNOLOGY GROUP LTD | ORD | G5876H105 | 5,943 | 125,000 | SH | Call | OTR | 125,000 | 0 | 0 | |
MICROSOFT CORP | COM | 594918104 | 391,052 | 1,758,168 | SH | OTR | 1,758,168 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 192,185 | 875,000 | SH | OTR | 875,000 | 0 | 0 | ||
MOMO INC | NOTE 1.250% 7/0 | 60879BAB3 | 93,459 | 110,077,000 | PRN | OTR | 110,077,000 | 0 | 0 | ||
NEW ORIENTAL ED & TECHNOLOGY | SPON ADR | 647581107 | 214,480 | 1,154,300 | SH | OTR | 1,154,300 | 0 | 0 | ||
NEW YORK TIMES CO | CL A | 650111107 | 338,852 | 6,545,329 | SH | OTR | 6,545,329 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 30,665 | 275,000 | SH | OTR | 275,000 | 0 | 0 | ||
NUANCE COMMUNICATIONS INC | DBCV 1.000%12/1 | 67020YAK6 | 13,052 | 7,000,000 | PRN | OTR | 7,000,000 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 54,474 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP | CL A | 698102100 | 29,250 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
PG&E CORP | COM | 69331C108 | 90,859 | 7,292,042 | SH | OTR | 7,292,042 | 0 | 0 | ||
PLAYA HOTELS & RESORTS NV | SHS | N70544106 | 89,219 | 14,994,867 | SH | OTR | 14,994,867 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 17,364 | 764,262 | SH | OTR | 764,262 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 13,755 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 48,888 | 2,425,000 | SH | OTR | 2,425,000 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 172,120 | 3,256,771 | SH | OTR | 3,256,771 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 37,638 | 2,107,400 | SH | OTR | 2,107,400 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 5,995 | 6,783,000 | PRN | OTR | 6,783,000 | 0 | 0 | ||
RAYTHEON TECHNOLOGIES CORP | COM | 75513E101 | 324,820 | 4,542,306 | SH | OTR | 4,542,306 | 0 | 0 | ||
READY CAPITAL CORP | COM | 75574U101 | 16,810 | 1,350,226 | SH | OTR | 1,350,226 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 10,968 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 90,836 | 1,050,000 | SH | OTR | 1,050,000 | 0 | 0 | ||
SALESFORCE COM INC | COM | 79466L302 | 313,555 | 1,409,045 | SH | OTR | 1,409,045 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 102,294 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 5,120 | 4,452,086 | SH | OTR | 4,452,086 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 5,241 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
SHERWIN WILLIAMS CO | COM | 824348106 | 286,149 | 389,366 | SH | OTR | 389,366 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 2,207 | 47,620 | SH | OTR | 47,620 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 510,346 | 1,365,000 | SH | Put | OTR | 1,365,000 | 0 | 0 | |
SURFACE ONCOLOGY INC | COM | 86877M209 | 9,240 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 5,202 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 88339KAA0 | 53,806 | 56,695,000 | PRN | OTR | 56,695,000 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 518,994 | 1,114,248 | SH | OTR | 1,114,248 | 0 | 0 | ||
TIFFANY & CO NEW | COM | 886547108 | 300,626 | 2,287,000 | SH | OTR | 2,287,000 | 0 | 0 | ||
TIGA ACQUISITION CORP | UNIT 99/99/9999 | G88672129 | 11,426 | 1,080,000 | SH | OTR | 1,080,000 | 0 | 0 | ||
T-MOBILE US INC | COM | 872590104 | 532,547 | 3,949,181 | SH | OTR | 3,949,181 | 0 | 0 | ||
TRANSUNION | COM | 89400J107 | 172,056 | 1,734,082 | SH | OTR | 1,734,082 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 10,839 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 487,353 | 2,228,104 | SH | OTR | 2,228,104 | 0 | 0 | ||
WABTEC | COM | 929740108 | 365,808 | 4,997,371 | SH | OTR | 4,997,371 | 0 | 0 | ||
WILLIS TOWERS WATSON PLC LTD | SHS | G96629103 | 202,780 | 962,500 | SH | OTR | 1 | 962,500 | 0 | 0 | |
XPO LOGISTICS INC | COM | 983793100 | 13,112 | 110,000 | SH | OTR | 110,000 | 0 | 0 | ||
ZEALAND PHARMA A/S | SPONSORED ADR | 98920Y304 | 18,329 | 510,000 | SH | OTR | 510,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 44,978 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 35,445 | 750,000 | SH | OTR | 750,000 | 0 | 0 |